Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
N
286750
vs
K
KOSPI 200
Over the past 12 months, NanoBrick Co Ltd has underperformed KOSPI 200, delivering a return of -30% compared to KOSPI 200's +125% growth.
Stocks Performance
286750 vs KOSPI 200
Performance Gap
286750 vs KOSPI 200
Performance By Year
286750 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
NanoBrick Co Ltd
Glance View
NanoBrick Co Ltd is a South Korean biopharmaceutical company that develops antibody-based medicines and related diagnostic tools. Its work centers on finding and engineering biological molecules that can be used to detect disease or become drug candidates, especially in areas like cancer and immune-related treatment. The company makes money by selling research products and by working with pharmaceutical partners on drug discovery and development projects. It may also earn income through licensing or collaboration agreements tied to its antibody technology. Its business is different from a typical drugmaker because much of its value comes from early-stage science, platform know-how, and partnering with larger healthcare companies rather than selling finished medicines directly to patients.